Global Branched Stent Grafts Market: Overview
Products in the global branched stent grafts market find applications in various EVAR or endovascular aneurysm repair procedures. EVAR for major aortic pathology, including aneurysms, traumatic ruptures, and dissections have gained widespread surgeon as well as patient acceptance owing to lower rates of morbidity as well as mortality. This trend is anticipated to fuel the demand in the global branched stent grafts market over the forecast period of 2021 to 2031. Increasing instances of cardiovascular diseases along with widespread acceptance of stenting procedures are also driving the growth in the global branched stent grafts market.
The research report closely evaluates the present conditions in the global branched stent grafts market and projects the market’s future trajectory during the forecast period of 2021 to 2031. It highlights certain trends and developments that can prove to be of great benefit to the upward climb of the global branched stent grafts market in the next three years. It also evaluates the changing landscape of the industry in coming years and projects the performance potential of the global branched stent grafts market during the forecast period of 2021 to 2031.
Expanding operations in future? To get the perfect launch ask for a custom report
Global Branched Stent Grafts Market: Key Trends and Drivers
Increase in the number of endovascular aneurysm repair or EVAR procedures, enhancements in the quality of patient care, and increasing innovations in medical technologies are few of the major factors influencing the growth in the global branched stent grafts market. Furthermore, increasing geriatric population as well as high prevalence of AAA or abdominal aortic aneurysm are also driving the growth in the global branched stent grafts market. However, decline in sales, reduction in growth rate, and deferring of elective surgeries caused by the outbreak of the novel corona virus and subsequent pandemic is hampering the development of the global branched stent grafts market. On the other hand, increasing demand for minimally invasive surgical procedures is also expected to favour the considerable growth of the global branched stent grafts market in coming years.
Global Branched Stent Grafts Market: Leading Players and Manufacturers
Some of the major incumbent players functional within the global branched stent grafts market include Medtronic, Alvimedica, Eucatech AG, Abbott Laboratories, Cardinal Health, Terumo Corp., Biotronik, Endocor GmbH, Merit Medical Systems, Cook Medical, and Boston Scientific Corporation, among others. Many players and manufacturers in the global branched stent grafts market are engaged in new product launches, collaborations and agreements, geographical expansions, and mergers and acquisitions in order to capture a substantial share in the industry. For example, Cook Medical received a breakthrough device designation by the FDA of the United States for their Zenith Fenestrated + Endovascular graft in March 2021, known as ‘ZFEN+’. However, this product is yet to be made commercially available for the public.
Request a sample to get extensive insights into the Branched Stent Grafts Market
Global Branched Stent Grafts Market: Regional Assessment
North America is likely to hold the largest share in the global branched stent grafts market in coming years owing to well established healthcare infrastructure, presence of various major players, as well as favourable reimbursement coverage in the region. It is anticipated that the North America region will experience fierce competition in the global branched stent grafts market in coming years owing to strong presence of many established and well-trenched industry players. On the other hand, another region expected to perform well in the overall global branched stent grafts market over the forecast period is Asia Pacific. This trend can be attributed to rapidly expanding field of medical tourism as well as increasing spending on healthcare in the region. Other notable factors stimulating growth in the global branched stent grafts market in Asia Pacific include availability of affordable treatment options, enhanced convenience, and presence of high quality healthcare and medical infrastructure in the region.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.